Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hypersplenism

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hypersplenism:

Pubmed Logo
A latent form of essential thrombocythemia presenting as portal cavernoma.
Essential thrombocythemia is frequently associated with abdominal...		13th November, 2009
Department of General Surgery, Sir Run Run Shaw Hospital, College of World J Gastroenterol. 2009 Nov 14;15(42):5368-70.
Liver and kidney disease in ciliopathies.
Hepatorenal fibrocystic diseases (HRFCDs) are among the most common...		31st October, 2009
Section on Human Biochemical Genetics, Medical Genetics Branch, National Am J Med Genet C Semin Med Genet. 2009 Nov 15;151C(4):296-306.
DOI Direct Link
Impact of Antithrombin III Concentrates on Portal Vein Thrombosis After Splenectomy in Patients With Liver Cirrhosis and Hypersplenism.
OBJECTIVE:: The aim of this study was to determine the role of...		30th October, 2009
From the *Department of Surgery and Science, Graduate School of Medical Ann Surg. 2009 Oct 27.
DOI Direct Link
Laparoscopic splenectomy and periesophagogastric devascularization with endoligature for portal hypertension in children.
BACKGROUND: Bleeding from esophagogastric varices is an importment...		30th October, 2009
Department of Pediatric Surgery, The Second Hospital of Hebei Medical J Laparoendosc Adv Surg Tech A. 2009 Aug;19(4):545-50.
DOI Direct Link
Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C.
Hepatitis C is the most common indication for orthotopic liver...		28th October, 2009
Division of Transplant Surgery, Department of Transplantation, Mayo World J Gastroenterol. 2009 Oct 28;15(40):5010-3.

→View more research publications.

Hypersplenism Clinical Trials:

Clinical Trials Logo
Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)

Hypersplenism Patents:

USPTO Logo
US Patent No.Title
5556758 Haloperoxidase acid optimum chemiluminescence assay system
6231880 Compositions and administration of compositions for the treatment of blood disorders
6277974 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
6413974 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
6422065 Method for testing a cell sample

→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hypersplenism scientists - we have details of around 241 individuals working on Hypersplenism .


This page has been viewed 413 times
Recent Search Terms used to find this page: hypersplenism management | hypersplenism | hypersplenism | portal and splenic venous thrombosis after splenectomy in patients with hypersplenism | management of hypersplenism | management of hypersplenism | management of hypersplenism | hypersplenism download | open splenectomy in hypersplenism | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hypersplenism across BioPortfolio, or for Hypersplenism Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.